Abstract Details
|
Emanuele Barca, MD, PhD
(Columbia University)
PRESENTER |
Dr. Barca has nothing to disclose. |
| Bardia Nourbakhsh, MD (Johns Hopkins University) | Dr. Nourbakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Nourbakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. The institution of Dr. Nourbakhsh has received research support from Genentech. The institution of Dr. Nourbakhsh has received research support from National MS Society . The institution of Dr. Nourbakhsh has received research support from Department of Defense. The institution of Dr. Nourbakhsh has received research support from NIH. The institution of Dr. Nourbakhsh has received research support from Axsome Therapeutics. The institution of Dr. Nourbakhsh has received research support from TG Therapeutics . |
| No disclosure on file | |
| No disclosure on file | |
| Darryl C. De Vivo, MD, FAAN (Columbia University) | Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics. |
| Salvatore DiMauro, MD (Columbia University Medical Center) | No disclosure on file |